Possible role of angiogenesis suppression in rats model of non alcoholic fatty liver disease | ||||
Bulletin of Egyptian Society for Physiological Sciences | ||||
Article 4, Volume 39, Issue 2, December 2019, Page 173-190 PDF (1.11 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/besps.2019.4410.1004 | ||||
View on SCiNiTO | ||||
Authors | ||||
Dalia Mohammed Abdel ghaffar Rezk 1; mohammed el mahdy sarhan2; hanaa ahmed abdel moniem3; amr medhat abbas3; mohammad eldosoky salama4 | ||||
1physiology department, faculty of medicine, mansoura university, talkha city, dakahlyia gov. | ||||
2physiology depatment, Faculty of Medicine, Mansoura University, Masoura, Egypt. | ||||
3physiology department, faculty of medicine, mansoura university, mansoura, eygpt | ||||
4physiology department, faculty of medicine, mansoura university, mansoura, eygpt. | ||||
Abstract | ||||
Objective:to evaluate development of angiogenesis in rats of NAFLD and to determine the protective effects of antiangiogenic therapy (sorafenib) in preventing the progression of NAFLD. Methods: 45 Albino rats (200-300 g) were divided into 3 groups (15 rats for each): Group I: Control group fed on an ordinary diet. Group II: rats received high fat, high fructose diet (HFD,HFr) with DEN ( twice weekly for 8 weeks, ip). Group III: rats received HFD, HFr + DEN + sorafenib orally for 8 weeks. Biochemical, histopathologial, and immunohistopathological examination were studied. Results: high fat, high fructose diet with DEN resulted in a significant elevation in the serum cholesterol, TG, LDL, and AST, and ALT, significantly lower levels of HDL and Albumin together with a significant decrease in hepatic GSH, Histopathological examination revealed that liver of untreated rats showed severe fatty infilteration (grade3). Immunohistochemical examination of liver of untreated NAFLD rats showed strong staining reactions against VEGF, α- SMA, CD31, and Caspase3 antibodies. Oral administration of sorafenib alleviated all these parameters. | ||||
Keywords | ||||
Angiogenesis; Non alcoholic fatty liver disease (NAFLD); Sorafenib; vascular endothelial growth factor (VEGF) | ||||
Statistics Article View: 310 PDF Download: 254 |
||||